Articles

We will be initiating targeted compliance reviews of selected listed medicines that are required to display a warning statement

TCMs sold in Australia are carefully regulated to ensure safety and quality.

Health professionals and consumers are advised that the oral antihistamine promethazine hydrochloride, sold as Phenergan and other generic brands, should not be used in children under 6 years of age.

We will adopt the 2021 Sunscreen Standard into therapeutic goods legislation. If you're a manufacturer or sponsor, find out what this means for you.

The Assessed listed medicine evidence guidelines have been updated, based on feedback, to aid sponsors in preparing their product applications.

Find out about changes to choline salicylate access, starting from October 2023.

The TGA has updated the Australian Regulatory Guidelines for Sunscreens (ARGS) to align with the data requirements for all ingredients proposed to be included in the Therapeutic Goods (Permissible Ingredients) Determination

New guidelines and mandatory requirements for listed medicines ingredients have come into effect on 1 February 2023.

The Pharmacovigilance Inspection Program (PVIP) Risk Assessment Survey is now open until 18 December 2022 for medicine sponsors to complete.

Information about how sunscreens are approved for supply in Australia and what you will see on sunscreen labels.

In Australia, a sports supplement can be classified as either a food or a medicine